跳至主要内容
临床试验/NCT03140384
NCT03140384撤回3 期

Compare the Different Routes of Administration of Misoprostol During Medicinal Abortion Between 7 and 9 Weeks of Amenorrhoea (SA)

Centre Hospitalier Universitaire, Amiens2 个研究点 分布在 1 个国家开始时间: 2017年8月20日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
撤回
试验地点
2
主要终点
Complete pregnancy evacuation on ultrasound at 3 weeks

研究概览

简要总结

In France, drug-induced abortion is allowed up to 9SA, after which the surgical route is preferred. Mifepristone 600mg is used 36-48 hours before the introduction of Misoprostol. This is recommended orally at a dose of 400 μg. There are currently several studies on the subject, including a meta-analysis of the 2011 Cochrane Database, but doses, routes of administration and gestational age differ in all studies. Currently, HAS recommends the vaginal route at the dose of 800μg for stopped pregnancies. It is therefore necessary to compare the different routes of administration of Misoprostol at the same dose to allow to change our French recommendations on the medicinal abortion and perhaps also to recommend the vaginal route in this indication.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women > 18 years hospitalized using abortions between 7 and 9 SA and after informed consent,
  • Affiliation to a social security scheme.

排除标准

  • Minor or major women under guardianship or curatorship
  • BMI <18.5 (thinness)
  • Ambulatory
  • Several abortions on the duration of the study
  • Take Mifepristone> 48 hours before taking Misoprostol
  • Contraindications to Misoprostol: Prostaglandin Allergy

研究组 & 干预措施

Administration of oral Misoprostol

Active Comparator

干预措施: Assess the efficacy and side effects of Misoprostol according to the route of administration (Biological)

Administration of Misoprostol vaginally

Active Comparator

干预措施: Assess the efficacy and side effects of Misoprostol according to the route of administration (Biological)

Administration of buccal Misoprostol

Active Comparator

干预措施: Assess the efficacy and side effects of Misoprostol according to the route of administration (Biological)

结局指标

主要结局

Complete pregnancy evacuation on ultrasound at 3 weeks

时间窗: 3 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验